Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33606004

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2021 Feb 23
First author
Voorhees PM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Voorhees PM
      type
      Author
    2. name
      Rodriguez C
      type
      Author
    3. name
      Reeves B
      type
      Author
    4. name
      Nathwani N
      type
      Author
    5. name
      Costa LJ
      type
      Author
    6. name
      Lutska Y
      type
      Author
    7. name
      Bobba P
      type
      Author
    8. name
      Hoehn D
      type
      Author
    9. name
      Pei H
      type
      Author
    10. name
      Ukropec J
      type
      Author
    11. name
      Qi M
      type
      Author
    12. name
      Lin TS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Voorhees PM
      type
      Author
    2. name
      Rodriguez C
      type
      Author
    3. name
      Reeves B
      type
      Author
    4. name
      Nathwani N
      type
      Author
    5. name
      Costa LJ
      type
      Author
    6. name
      Lutska Y
      type
      Author
    7. name
      Bobba P
      type
      Author
    8. name
      Hoehn D
      type
      Author
    9. name
      Pei H
      type
      Author
    10. name
      Ukropec J
      type
      Author
    11. name
      Qi M
      type
      Author
    12. name
      Lin TS
      type
      Author
    bibliography ids
    1. nci-bib-d56053f4cddf4e7568c6039f
    book metadata
    content sha256
    e46ebd0c7ccaf5a2d91f8141c04a7a6f16f0594a9a8032a95926c0b451142d61
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2020003642
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33606004
    immutable id
    pubmed:33606004@e46ebd0c7ccaf5a2d91f8141c04a7a6f16f0594a9a8032a95926c0b451142d61
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    4
    name
    Blood advances
    nlm unique id
    101698425
    pages
    1092-1096
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33606004
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      6b63731eba468be6dd9dcb111581845107392562d77105aa83887a50291aea7c
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Feb 23
      precision
      day
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33606004/
      title
      Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.

      Preserved source evidence · Not medical advice